Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF-07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS-CoV-2, in Healthy Adult Participants. - Zhu T; Pawlak S; Toussi SS; Hackman F; Thompson K; Song W; Salageanu J; Winter E; Shi H; Winton J; Binks M (Clinical pharmacology in drug development, 2022)